Lovatt

GenTech’s ’20-’21 Annual’s Reflect Tremendous 300% Growth on a YOY Basis with TTM Rising to $1.3m

Retrieved on: 
Friday, January 28, 2022
Storm, Growth, CEO, TTM, Dietary supplement, Functional food, Lovatt, 200s, Gentech Pharmaceutical, Calendar, Food science, Trailing twelve months, Company, GLOBE, Acquisition, News, OTC Markets Group, Yield10 Bioscience, Music, Renewable energy

The Trailing Twelve Months(TTM) revenues also rises to an impressive $1.3m+ which is an incredible growth curve from companies in their first full calendar year of operations.

Key Points: 
  • The Trailing Twelve Months(TTM) revenues also rises to an impressive $1.3m+ which is an incredible growth curve from companies in their first full calendar year of operations.
  • With GenTechs new brands Storm and Fizzique coming on stream already, the revenue estimates previously disseminated remain fully on track.
  • David Lovatt, CEO of GenTech Holdings commented, These figures continue to show exceptional growth relative to our 2020 revenues.
  • However, we anticipate a much more aggressive growth curve than that, based on the addition of Fizzique and Storm to our offerings.

GenTech Provides Year-to-Date Performance Update: 2021 Revenues on Pace for $1.3M, with 2022 Showing Potential for 800% Growth

Retrieved on: 
Monday, October 25, 2021
Storm, COVID-19, Projection, Lovatt, CO, Gentech Pharmaceutical, FINRA, USA, OTC Markets Group, Marketing, Company, Dietary supplement, CEO, Growth, News, Yield10 Bioscience, Food science, Acquisition, GLOBE, Ticker, Renewable energy, 3D printing

Provisional topline revenue numbers for the nine months to September 30 show Gross Consolidated Revenues from operations currently at $745,900.

Key Points: 
  • Provisional topline revenue numbers for the nine months to September 30 show Gross Consolidated Revenues from operations currently at $745,900.
  • David Lovatt, CEO of GenTech Holdings, commented, These figures show exceptional growth relative to 2020 performance data.
  • If you add in a full inventory for NxtBar and Nature Soothie, our 2022 revenue outlook jumps to over $3.5 million.
  • This press release may contain forward-looking statements, including information about management's view of GenTech, Inc.'s future expectations, plans and prospects.

GenTech Submits Lease Offers for Next Three “Healthy Leaf CBD-Infusion Café” Locations

Retrieved on: 
Friday, September 13, 2019
Cars, Cannabis in New Jersey, Faulkner Act, Montclair, New Jersey, Montclair, Lovatt, Nissan Leaf, Motor vehicles, Transport

We are on track and even ahead of schedule with our Montclair location, and its time to start expanding to our next three locations, commented David Lovatt, GenTech CEO.

Key Points: 
  • We are on track and even ahead of schedule with our Montclair location, and its time to start expanding to our next three locations, commented David Lovatt, GenTech CEO.
  • Because the lease offers have not been officially accepted, the Company cannot reveal specifics that might disclose the precise locations.
  • However, its initial Montclair location represents a strong characterization of the model being sought by the Company for subsequent locations.
  • The market has been prepped just right for what we are set to roll out with the Healthy Leaf, concluded Lovatt.